Cambridge 劍橋CANTAB 測驗- RVP 快速視覺訊息處理測驗

文章推薦指數: 80 %
投票人數:10人

快速視覺訊息處理測驗(Rapid Visual Information Processing) CANTAB 劍橋認知心理衡鑑系統中的注意力測驗之一. PRODUCT 首頁 產品資訊 PRODUCT 首頁 產品資訊 Cambridge劍橋CANTAB測驗-RVP快速視覺訊息處理測驗 產品型號:RVP 廠牌名稱:CambridgeCognition 快速視覺訊息處理測驗(RapidVisualInformationProcessing) CANTAB劍橋認知心理衡鑑系統中的注意力測驗之一 #認知測驗 #CANTAB 我要詢價 返回列表 產品特點 簡介:快速視覺訊息處理(RVP)是測試注意力持久性的一個測驗(與連續表現作業ContinuousPerformanceTask相似)。

在許多以藥物發展的疾病模型研究中,已被證明是有用的。

對於大腦頂葉和額葉區域功能障礙相當敏感,且對於一般表現的測量亦相當敏感。

施測時間:大約7分鐘。

作業:電腦螢幕中間呈現一個白色方塊,以隨機亂數的次序於方框中央顯示數字2-9,數字變化的速度是每分鐘變化100次。

受測者需要偵測目標的數字順序(例如:2-4-6,3-5-7,4-6-8),並以反應鍵盤盒做出反應。

測驗結果:RVP的9個測量結果包含延遲時間、機率和敏感度(依據訊息偵測理論計算),以及點擊、錯失、錯誤警報和拒絕。

CANTAB ConnectResearch劍橋神經認知測驗介紹 產品規格 主要參考文獻 CANTABDepressionBattery •RockPL,RoiserJP,RiedelWJ,BlackwellAD.Cognitiveimpairmentindepression:asystematicreviewandmeta-analysis.PsycholMed.2013Oct29:1-12.[Epubaheadofprint] •RoiserJP,SahakianBJ.Hotandcoldcognitionindepression.CNSSpectr.2013Jun;18(3):139-49. •EgerháziA,BallaP,RitzlA,VargaZ,FrecskaE,BereczR.AutomatedNeuropsychologicalTestBatteryindepression--preliminarydata.NeuropsychopharmacolHung.2013Mar;15(1):5-11. •GreerTL,SunderajanP,GrannemannBD,KurianBT,TrivediMH.Doesduloxetineimprovecognitivefunctionindependentlyofitsantidepressanteffectinpatientswithmajordepressivedisorderandsubjectivereportsofcognitivedysfunction?DepressResTreat.2014;2014:627863. •vanTolMJ,vanderWeeNJ,DemenescuLR,NielenMM,AlemanA,RenkenR,vanBuchemMA,ZitmanFG,VeltmanDJ.FunctionalMRIcorrelatesofvisuospatialplanninginout-patientdepressionandanxiety.ActaPsychiatrScand.2011Oct;124(4):273-84. •PapakostasGI.Cognitivesymptomsinpatientswithmajordepressivedisorderandtheirimplicationsforclinicalpractice.JClinPsychiatry.2014Jan;75(1):8-14. -更多資訊請見:http://www.cambridgecognition.com/academic-studies/product/cantab-depression-battery#sthash.DbwguDPJ.HoD2Vjyp.dpuf CANTABAlzheimer’s(Dementia)Battery •FowlerKS,SalingMM,ConwayEL,SempleJM,LouisWJ.PairedassociateperformanceintheearlydetectionofDAT.JournaloftheInternationalNeuropsychologicalSociety:JINS.2002;8(1):58-71. •EgerhaziA,BereczR,BartokE,DegrellI.AutomatedNeuropsychologicalTestBattery(CANTAB)inmildcognitiveimpairmentandinAlzheimer’sdisease.Progressinneuro-psychopharmacology&biologicalpsychiatry.2007;31(3):746-51.Epub2007/02/10. •BlackwellAD,SahakianBJ,VeseyR,SempleJM,RobbinsTW,HodgesJR.Detectingdementia:novelneuropsychologicalmarkersofpreclinicalAlzheimer’sdisease.DementGeriatrCognDisord.2004;17(1-2):42-8.Epub2003Oct13. •GreigNH,SambamurtiK,YuQS,BrossiA,BruinsmaGB,LahiriDK.Anoverviewofphenserinetartrate,anovelacetylcholinesteraseinhibitorforthetreatmentofAlzheimer’sdisease.CurrAlzheimerRes.2005;2(3):281-90. •AtackJR.PreclinicalandclinicalpharmacologyoftheGABAAreceptoralpha5subtype-selectiveinverseagonistalpha5IA.Pharmacology&therapeutics.2010;125(1):11-26.Epub2009/09/23. -更多資訊請見:http://www.cambridgecognition.com/academic-studies/product/cantab-dementia-battery#sthash.rL7KE7eu.dpuf CANTAB ADHDBattery •BedardAC,MartinussenR,IckowiczA,TannockR.Methylphenidateimprovesvisual-spatialmemoryinchildrenwithattention-deficit/hyperactivitydisorder.JAmAcadChildAdolescPsychiatry.2004Mar;43(3):260-8. •ChamberlainSR,RobbinsTW,Winder-RhodesS,MüllerU,SahakianBJ,BlackwellAD,BarnettJH.Translationalapproachestofrontostriataldysfunctioninattention-deficit/hyperactivitydisorderusingacomputerizedneuropsychologicalbattery.BiolPsychiatry.2011Jun15;69(12):1192-203. •ChamberlainSR,DelCampoN,DowsonJ,MüllerU,ClarkL,RobbinsTW,SahakianBJ.Atomoxetineimprovedresponseinhibitioninadultswithattentiondeficit/hyperactivitydisorder.BiolPsychiatry.2007Nov1;62(9):977-84. •DeVitoEE,BlackwellAD,ClarkL,KentL,DezseryAM,TurnerDC,AitkenMR,SahakianBJ.Methylphenidateimprovesresponseinhibitionbutnotreflection-impulsivityinchildrenwithattentiondeficithyperactivitydisorder(ADHD).Psychopharmacology(Berl).2009Jan;202(1-3):531-9.doi:10.1007/s00213-008-1337-y.Epub2008Sep26. •PotterAS,NewhousePA.(2004).Effectsofacutenicotineadministrationonbehavioralinhibitioninadolescentswithattention-deficit/hyperactivitydisorder.Psychopharmacology(Berl).2004Nov;176(2):182-94. •ValeraEM,FaraoneSV,MurrayKE,SeidmanLJ.Meta-analysisofstructuralimagingfindingsinattention-deficit/hyperactivitydisorder.BiolPsychiatry.2007Jun15;61(12):1361-9. -更多資訊請見:http://www.cambridgecognition.com/academic-studies/product/cantab-adhd-battery#sthash.20uQKe6j.dpuf CANTABSchizophreniaBattery •BarnettJH,RobbinsTW,LeesonVC,SahakianBJ,JoyceEM,BlackwellAD.Assessingcognitivefunctioninclinicaltrialsofschizophrenia.NeurosciBiobehavRev.2010Jul;34(8):1161-77.doi:10.1016/j.neubiorev.2010.01.012.Epub2010Jan25. •JoyceE,HuttonS,MutsatsaS,GibbinsH,WebbE,PaulS,RobbinsT,BarnesT.Executivedysfunctioninfirst-episodeschizophreniaandrelationshiptodurationofuntreatedpsychosis:theWestLondonStudy.BrJPsychiatrySuppl.2002Sep;43:s38-44. •SaleemMM,HarteMK,MarshallKM,ScallyA,BrewinA,NeillJC.Firstepisodepsychosispatientsshowimpairedcognitivefunction--astudyofaSouthAsianpopulationintheUK.JPsychopharmacol.2013Apr;27(4):366-73.Epub2013Feb20. •ZhornitskyS,AubinG,DesfossésJ,RizkallahE,PampoulovaT,LippO,ChiassonJP,StipE,PotvinS.Predictorsofcommunityfunctioninginschizophreniaandsubstanceusedisorderpatients.CommunityMentHealthJ.2013Jun;49(3):317-22.Epub2012Jul31. •LevkovitzY,MendlovichS,RiwkesS,BrawY,Levkovitch-VerbinH,GalG,FennigS,TrevesI,KronS.Adouble-blind,randomizedstudyofminocyclineforthetreatmentofnegativeandcognitivesymptomsinearly-phaseschizophrenia.JClinPsychiatry.2010Feb;71(2):138-49.Epub2009Nov3. -更多資訊請見:http://www.cambridgecognition.com/academic-studies/product/cantab-schizophrenia-battery#sthash.OMAEK5Un.dpuf 應用領域 用於:CANTABADHDbattery、CANTABAlzheimer’sbattery、CANTABschizophreniabattery和CANTABdepressionbattery 返回列表 相關產品 Cambridge劍橋CANTABConnectResearch 詢價表單 確認送出 填寫完成 您可以繼續瀏覽或轉移至產品列表! 回產品列表 COPYRIGHT©2018KYSTechnologyCo.,Ltd.RIGHTSRESERVED.DESIGNBYLAZYWeb.



請為這篇文章評分?